Splice-Switching Antisense Oligonucleotides Reduce LRRK2 Kinase Activity in Human LRRK2 Transgenic Mice

Parkinson’s disease (PD) is a progressive neurological disorder estimated to affect 7–10 million people worldwide. There is no treatment available that cures or slows the progression of PD. Elevated leucine-rich repeat kinase 2 (LRRK2) activity has been associated with genetic and sporadic forms of...

Descripción completa

Detalles Bibliográficos
Autores principales: Korecka, Joanna A., Thomas, Ria, Hinrich, Anthony J., Moskites, Alyssa M., Macbain, Zach K., Hallett, Penelope J., Isacson, Ole, Hastings, Michelle L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393423/
https://www.ncbi.nlm.nih.gov/pubmed/32736291
http://dx.doi.org/10.1016/j.omtn.2020.06.027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393423/
https://www.ncbi.nlm.nih.gov/pubmed/32736291
http://dx.doi.org/10.1016/j.omtn.2020.06.027

Ejemplares similares